mRNA Platform Global Strategic Research Report 2024
April 05, 2024 09:17 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "mRNA Platform - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The report delves into the mRNA...
Global Human Vaccines Market (2023-2028)
March 27, 2024 14:03 ET
|
Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Global Human Vaccines Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis" report has been added to ResearchAndMarkets.com's...
Global Vaccines Market Research Report 2024: Focus on Commercialized and Developmental Vaccines
March 21, 2024 07:40 ET
|
Research and Markets
Dublin, March 21, 2024 (GLOBE NEWSWIRE) -- The "The World Market for Vaccines, 2024" report has been added to ResearchAndMarkets.com's offering. The World Market for Vaccines, 2024 offers the...
HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress
March 20, 2024 16:00 ET
|
HilleVax, Inc.
Topline data from NEST-IN1 Phase 2B clinical study of HIL-214 in infants expected in mid-2024 Enrollment for NEST-IN1 study completed in Q2 2023 $303.5 million of cash, cash equivalents and...
Global BCG Vaccines Market Forecast Report: Compound Annual Growth Rate (CAGR) of 5.90% is Forecast Through the End of 2028
February 28, 2024 11:10 ET
|
Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "BCG Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's...
Vaccine Adjuvants Market Global Industry Analysis 2018-2028: Expanding Human Vaccine Adjuvants Segment and Rising Infectious Disease Threats Propel Market Advancements
February 21, 2024 11:34 ET
|
Research and Markets
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ...
Global Pneumococcal Vaccine Market to Showcase a 6.26% CAGR till 2028: Next-Gen Pneumococcal Vaccines Revolutionizing Protection, Driving Market Growth Through Combination Products
February 09, 2024 10:06 ET
|
Research and Markets
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Pneumococcal Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ...
Conjugate Vaccines Market Projected at $18.47 Billion by 2028, Driven by Major Advances in Preventive Healthcare and Technology
February 09, 2024 09:46 ET
|
Research and Markets
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Conjugate Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference
February 05, 2024 16:05 ET
|
HilleVax, Inc.
BOSTON, Feb. 05, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it...
Recombinant Vaccines Research Report 2024: Market Poised for Accelerated Growth, Set to Reach $34.18 Billion by 2034 from $10.14 Billion in 2023
January 31, 2024 11:23 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Recombinant Vaccines Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global...